Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

During the Trading Day
5.49 +0.28 / +5.37%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.49 0.00 / 0.00%
Volume: 65.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Operating ActivitiesNet Income / Starting Line-40.3M-27.7M-26.9M-30.7M
Total Other Cash Flow13.6M4.3M4.0M4.5M
Funds From Operations-25.9M-23.3M-22.7M-26.1M
Funds From/For Other Operating Expenses7.7M12.0M15.3M2.8M
Net Cash Flow - Operating Activities-33.6M-35.3M-38.0M-28.8M
InvestingIncrease In Investments-46.0K0.000.000.00
Decrease In Investments22.6M11.5M0.000.00
Capital Expenditures-290.0K-61.0K-103.0K-268.0K
Net Cash Flow Investing22.3M11.4M-103.0K-268.0K
FinancingShort Term Borrowings0.
Long Term Borrowings0.
Long Term Debt Reduction0.
Net Proceeds Stock Sale-6.1M126.6M1.3M-8.2M
Common Preferred Redeemed7.5M-8.2M0.008.2M
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing0.000.0015.0K0.00
Net Cash Flow - Financing1.4M118.4M1.3M9.0K
Exchange RateEffect of Exchange Rate on Cash0.00----0.00--
Net Change In Cash-9.8M94.6M-36.7M-29.1M